# LIFE-BTK Randomized Controlled Trial

Study · id `cardio:ct-nct04227899` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04227899](<https://clinicaltrials.gov/study/NCT04227899>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04227899

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 261 participants.

## Technical summary

Registry record NCT04227899. Randomized; single masking; primary purpose treatment. Start 2020-08-18 (actual); primary completion 2023-08-17 (actual). Results posted on 2024-09-19.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 261 participants (enrolled count; ClinicalTrials.gov record NCT04227899, source copy `cardio:ctgov-nct04227899-2025-12-30`, retrieved 2026-10-31)
- Started: 2020-08-18 (actual) (ClinicalTrials.gov record NCT04227899, source copy `cardio:ctgov-nct04227899-2025-12-30`, retrieved 2026-10-31)
- Primary completion: 2023-08-17 (actual) (ClinicalTrials.gov record NCT04227899, source copy `cardio:ctgov-nct04227899-2025-12-30`, retrieved 2026-10-31)
- Completion: 2027-07 (anticipated) (ClinicalTrials.gov record NCT04227899, source copy `cardio:ctgov-nct04227899-2025-12-30`, retrieved 2026-10-31)
- Results first posted: 2024-09-19 (ClinicalTrials.gov record NCT04227899, source copy `cardio:ctgov-nct04227899-2025-12-30`, retrieved 2026-10-31)
- Countries: United States; Australia; Hong Kong SAR China; New Zealand; Singapore; Taiwan (ClinicalTrials.gov record NCT04227899, source copy `cardio:ctgov-nct04227899-2025-12-30`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04227899-2025-12-30`, retrieved 2026-10-31)

## The registry's words

- Brief title: LIFE-BTK Randomized Controlled Trial
- Acronym: LIFE-BTK
- Condition: Critical Limb Ischemia (CLI)
- Intervention (Device): Esprit BTK Device
- Intervention (Device): Percutaneous Transluminal Angioplasty (PTA) Device
- Lead sponsor: Abbott Medical Devices
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Abbott (`cardio:abbott`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Drug-Eluting Resorbable Scaffold versus Angioplasty for Infrapopliteal Artery Disease (`cardio:pubmed-37888915`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Drug-Eluting Resorbable Scaffold Versus Balloon Angioplasty for Below-the-Knee Peripheral Artery Disease: 2-Year Results From the LIFE-BTK Trial (`cardio:pubmed-40927852`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Long-Term Outcomes of a Drug-Eluting Resorbable Scaffold vs Angioplasty in Infrapopliteal Chronic Limb-Threatening Ischemia: 3-Year Results From the LIFE-BTK Trial (`cardio:pubmed-42126372`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 26a9080806e46bd91c8f9f9991421aa82c27e22257220a3f0d1c6b9cbbeebe30
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
